Analyst Price Targets — NUVL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 24, 2026 9:04 am | — | Bernstein | $124.00 | $123.44 | TheFly | Nuvalent downgraded to Market Perform from Outperform at Bernstein |
| June 10, 2026 11:01 am | Brad Canino | Guggenheim | $124.00 | $123.25 | TheFly | Nuvalent downgraded to Neutral from Buy at Guggenheim |
| June 10, 2026 6:53 am | David Dai | UBS | $124.00 | $123.25 | StreetInsider | UBS Downgrades Nuvalent (NUVL) to Neutral |
| June 9, 2026 8:35 pm | — | Truist Financial | $124.00 | $123.25 | TheFly | Nuvalent downgraded to Hold from Buy at Truist |
| June 9, 2026 5:14 pm | — | Barclays | $124.00 | $123.16 | TheFly | Nuvalent downgraded to Equal Weight from Overweight at Barclays |
| June 9, 2026 3:13 pm | — | Robert W. Baird | $122.85 | $123.13 | TheFly | Nuvalent downgraded to Neutral from Outperform at Baird |
| June 9, 2026 2:22 pm | — | Stifel Nicolaus | $124.00 | $123.20 | TheFly | Nuvalent downgraded to Hold from Buy at Stifel |
| June 9, 2026 1:07 pm | Eva Fortea Verdejo | Wells Fargo | $124.00 | $122.88 | TheFly | Nuvalent downgraded to Equal Weight from Overweight at Wells Fargo |
| June 9, 2026 1:06 pm | — | H.C. Wainwright | $124.00 | $122.85 | TheFly | Nuvalent downgraded to Neutral from Buy at H.C. Wainwright |
| June 9, 2026 12:24 pm | — | Piper Sandler | $124.00 | $122.88 | TheFly | Nuvalent downgraded to Neutral from Overweight at Piper Sandler |
Latest News for NUVL
Fifth Third Bancorp bought a new position in shares of Nuvalent, Inc. (NASDAQ: NUVL) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 23,621 shares of the company's stock, valued at approximately $2,420,000. Other institutional investors and hedge funds
BALA CYNWYD, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
BALA CYNWYD, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propo
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Nuvalent, Inc. (NasdaqGS: NUVL) to GSK plc (NYSE: GSK). Under the terms of the proposed transaction, shareholders of Nuvalent will receive $124.00 in cash for each share of Nuvalent that they own. KSF is seeking to…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NUVL.
U.S. House Trading
No House trades found for NUVL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.